Rig, I took a starter last week on the retrace. Added today. Like IMTS, I don't mind averaging up along the way. The CEO is unlike most in OTC land, a real professional with a history of building value in companies. SENS could easily see the .20's in Feb, and bigger gains over the next year or so.
News 
Market Data 
Discover 
